Research and Markets: Pharmaceutical Industry in Sweden - Includes Data on Market Size and Segmentation, Key Trends and Competitive Landscape, Leading Companies & Much More

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/e4ad7f/pharmaceutical_ind) has announced the addition of the "Pharmaceutical Industry in Sweden" report to their offering.

The birth origins of the Pharmaceutical Industry can be traced back to more humble antecedents than just chemistry labs. The earliest incidents of recognition of the antiseptic properties of the dyestuffs is around the late 19th century. The invention of penicillin can yet be recognized as a major milestone for the emergent industry which firmly consolidated its R&D efforts in the 1950's. Further in the 1960's the patent regulation support gave a further impetus to the industry in new discoveries and relaxed controls on clinical development with the booming spend on healthcare as economies boomed globally.

The global presence of the pharmaceutical industry is evident with the roll out of continent specific R&D programs and drugs which help companies maximize penetration of markets and garner increased revenues with intercontinental treatment demand of patients being serviced from often one or two mega research centers in the continent.

The pharmaceutical industry is under mounting scrutiny because of rapidly increasing expenditures for drugs worldwide. Drug expenditures are now the fastest-growing component of health care costs, increasing at the rate of about 15 percent per year. They account for about eight percent of health care spending, and at their current rate of increase, they will soon surpass spending for physicians' services and, for many health care organizations, the costs of hospitalization.

This report brings you a complete analysis of the Pharmaceutical Industry in Sweden. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, offshoring in the pharmaceutical industry, economic trends in the industry, competition in the industry, and the key players in the pharmaceutical industry in Sweden, complete with a SWOT analysis of the leading companies in the market.

Key Topics Covered:

A. Executive Summary

B. The Global Pharmaceutical Industry - A Brief Profile B.1 Industry Definition B.2 Industry Overview B.3 Industry Forecast

C. TRIPS and the Global Pharmaceutical Industry C.1 Introduction C.2 Product Patents and Prices of Medicines C.3 Product Patents and Research and Development C.4 Patents and Technology Transfer C.5 Flexibility in the Agreement

D. Pharmaceutical Industry in Sweden D.1 Industry Overview D.2 Industry Value and Market Share D.3 Industry Segmentation D.4 Industry Forecast

E. Competition in the Industry

F. Leading Players in the Market F.1 AstraZeneca Plc F.2 Pfizer Inc F.3 Novartis AG

G. Appendix G.1 Offshoring in the Pharmaceutical Sector G.2.1 Offshoring of R&D G.3.1 Offshoring of Pharmaceutical Manufacturing Processes

H. Glossary of Terms

Companies Mentioned:

• Pfizer Inc
• Novartis AG
• AstraZeneca Plc

For more information visit http://www.researchandmarkets.com/research/e4ad7f/pharmaceutical_ind